These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7925565

  • 1. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells.
    Scully R, Qin S, Cobbold S, Waldmann H.
    Eur J Immunol; 1994 Oct; 24(10):2383-92. PubMed ID: 7925565
    [Abstract] [Full Text] [Related]

  • 2. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM, Fava L, Chen J, Plain KM, Boyd RA, Spicer ST, Berger MF.
    J Immunol; 1998 Nov 15; 161(10):5147-56. PubMed ID: 9820484
    [Abstract] [Full Text] [Related]

  • 3. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.
    Cobbold SP, Martin G, Waldmann H.
    Eur J Immunol; 1990 Dec 15; 20(12):2747-55. PubMed ID: 1980112
    [Abstract] [Full Text] [Related]

  • 4. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG, Liu Z, Wu Y.
    Transpl Immunol; 2005 Oct 15; 15(1):9-16. PubMed ID: 16223668
    [Abstract] [Full Text] [Related]

  • 5. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
    Chen Z, Cobbold S, Metcalfe S, Waldmann H.
    Eur J Immunol; 1992 Mar 15; 22(3):805-10. PubMed ID: 1547823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T cell suppression in transplantation tolerance through linked recognition.
    Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H.
    J Immunol; 1996 May 15; 156(10):3602-7. PubMed ID: 8621893
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M.
    Clin Transplant; 1996 Aug 15; 10(4):357-63. PubMed ID: 8884109
    [Abstract] [Full Text] [Related]

  • 10. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND, Fluck NC, Roelen DL, Mellor AL, Morris PJ, Wood KJ.
    Eur J Immunol; 1997 Jul 15; 27(7):1591-600. PubMed ID: 9247566
    [Abstract] [Full Text] [Related]

  • 11. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar 15; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH, Choi SE, Kim YH, Yang SH, Park JH, Park CS, Kim Y, Kim JS, Kim SJ, Simpson E, Park CG.
    Transplantation; 2008 Nov 27; 86(10):1352-60. PubMed ID: 19034003
    [Abstract] [Full Text] [Related]

  • 13. Allo-I-J determinants participate in maintenance of neonatal H-2 tolerance.
    Mohler KM, Strome PG, Streilein JW.
    J Immunol; 1987 Jan 01; 138(1):70-7. PubMed ID: 2946781
    [Abstract] [Full Text] [Related]

  • 14. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL.
    Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596
    [Abstract] [Full Text] [Related]

  • 15. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K.
    J Immunol; 1990 Dec 15; 145(12):4026-36. PubMed ID: 2147933
    [Abstract] [Full Text] [Related]

  • 16. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients.
    Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW.
    J Immunol; 1998 Jun 15; 160(12):5765-72. PubMed ID: 9637486
    [Abstract] [Full Text] [Related]

  • 17. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H, Chilton PM, Huang Y, Schanie CL, Yan J, Ildstad ST.
    Transplantation; 2007 Apr 15; 83(7):954-63. PubMed ID: 17460568
    [Abstract] [Full Text] [Related]

  • 18. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K, Yung-Yun K, Omoto K, Umesue M, Murakami Y, Matsuzaki G, Nomoto K.
    Transplantation; 1995 Feb 15; 59(3):395-401. PubMed ID: 7871570
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA, Landeros K, Kataoka M, Flye MW.
    Transpl Immunol; 2003 Feb 15; 11(1):23-9. PubMed ID: 12727472
    [Abstract] [Full Text] [Related]

  • 20. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J, Liu J, Xie S.
    Zhonghua Yi Xue Za Zhi; 2001 May 25; 81(10):593-6. PubMed ID: 11798930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.